Purpose: To evaluate the ability of topical diclofenac to decrease cor
neal opacity after excimer laser photorefractive keratectomy (PRK). Me
thods: Twenty New Zealand white rabbits underwent a unilateral 193-nm
excimer laser myopic photorefractive keratectomy to correct 5 diopters
. There were four groups of five rabbits each. The first group of rabb
its received postoperative topical treatment with placebo (Voltaren Op
hthalmic vehicle), the second group received topical 0.1% diclofenac,
the third group received topical corticosteroid (0.1% fluorometholone)
, and the fourth group received diclofenac and fluorometholone. In the
first month, the topical drugs were applied four times daily, and in
the second month twice daily. Corneal haze was graded from 0 (totally
clear) to 4 (completely opaque cornea). Slit-lamp pictures were obtain
ed at weeks 2, 4, and 8, and keratometry readings was performed at wee
ks 4 and 8. At week 8, the rabbits were killed, and the eyes were subm
itted for histologic examination. Results: At week 8, there was less c
orneal haze in the diclofenac-treated animals and in the fluorometholo
ne-treated animals than in the control group, but only in the diclofen
ac-treated group was the difference statistically significant. Combina
tion treatment with diclofenac and fluorometholone did not result in a
further decrease in haze. Conclusions: These data suggest that diclof
enac and fluorometholone may influence corneal wound healing in rabbit
s after excimer laser PRK and support a potential role for using topic
al nonsteroidal anti-inflammatory drugs in preventing the development
of excessive corneal haze after excimer laser surgery.